Ajanta Pharma Limited
NSE:AJANTPHARM.NS
2985.6 (INR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 42,087.1 | 37,426.4 | 32,841.3 | 28,470.2 | 25,618 | 20,164.5 | 20,595.9 | 19,164.3 | 17,075.3 | 14,550.8 | 11,810.9 | 9,218.9 | 6,773.969 | 5,048.717 | 4,077.146 | 3,493.445 | 3,093.746 | 2,580.054 | 2,297.031 | 1,985.739 |
| Cost of Revenue
| 21,023.1 | 10,504 | 8,867.2 | 6,823.9 | 6,902.3 | 4,235 | 4,717 | 4,705.8 | 4,500.1 | 3,865.2 | 3,599.5 | 3,119 | 2,299.437 | 1,729 | 1,455.437 | 1,270.578 | 1,401.745 | 1,400.45 | 1,219.436 | 1,034.41 |
| Gross Profit
| 21,064 | 26,922.4 | 23,974.1 | 21,646.3 | 18,715.7 | 15,929.5 | 15,878.9 | 14,458.5 | 12,575.2 | 10,685.6 | 8,211.4 | 6,099.9 | 4,474.532 | 3,319.717 | 2,621.709 | 2,222.867 | 1,692.001 | 1,179.604 | 1,077.595 | 951.329 |
| Gross Profit Ratio
| 0.5 | 0.719 | 0.73 | 0.76 | 0.731 | 0.79 | 0.771 | 0.754 | 0.736 | 0.734 | 0.695 | 0.662 | 0.661 | 0.658 | 0.643 | 0.636 | 0.547 | 0.457 | 0.469 | 0.479 |
| Reseach & Development Expenses
| 2,080 | 2,370.1 | 2,043.4 | 1,389.1 | 1,641.7 | 1,760.2 | 1,862.4 | 1,503.3 | 1,064.7 | 700.7 | 590.4 | 412.9 | 0 | 248.837 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,295.4 | 710.7 | 545.9 | 384 | 283.1 | 208.4 | 300.4 | 263.2 | 214.2 | 159.3 | 133.6 | 116.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 2,531.2 | 2,267.1 | 2,975.4 | 2,384.1 | 3,044.1 | 2,409.2 | 2,269.1 | 2,082.6 | 1,922.6 | 1,931.3 | 1,609.3 | 1,335.1 | 0 | 0 | 487.563 | 0 | 0 | 0 | 198.446 | 200.53 |
| SG&A
| 8,618.6 | 2,977.8 | 3,521.3 | 2,768.1 | 3,327.2 | 2,617.6 | 2,569.5 | 2,345.8 | 2,136.8 | 2,090.6 | 1,742.9 | 1,451.3 | 0 | 0 | 487.563 | 0 | 0 | 0 | 198.446 | 200.53 |
| Other Expenses
| 459.1 | 986.4 | 152.9 | 56 | 68.7 | 11.5 | 5.1 | 39.7 | 7 | 2.9 | 8.9 | 3 | 3,323.617 | 2,327.005 | 1,562.552 | 1,689.209 | 1,241.766 | 862.112 | 623.684 | 554.71 |
| Operating Expenses
| 10,698.6 | 20,397.9 | 15,855.3 | 12,723.9 | 12,611 | 10,898.9 | 9,807.2 | 7,784.8 | 7,149.4 | 6,149.2 | 4,962.7 | 4,196.7 | 3,323.617 | 2,575.842 | 2,050.115 | 1,689.209 | 1,241.766 | 862.112 | 822.13 | 755.24 |
| Operating Income
| 10,365.4 | 6,617.8 | 8,078.7 | 8,902.8 | 5,877.1 | 4,945.8 | 6,071.7 | 6,673.7 | 5,425.8 | 4,536.4 | 3,248.7 | 1,903.2 | 1,150.915 | 743.875 | 571.594 | 533.658 | 450.235 | 317.492 | 255.465 | 196.089 |
| Operating Income Ratio
| 0.246 | 0.177 | 0.246 | 0.313 | 0.229 | 0.245 | 0.295 | 0.348 | 0.318 | 0.312 | 0.275 | 0.206 | 0.17 | 0.147 | 0.14 | 0.153 | 0.146 | 0.123 | 0.111 | 0.099 |
| Total Other Income Expenses Net
| 773.9 | 834.7 | 1,016.1 | 99 | 762.6 | 196.9 | 153.8 | -192 | 48.2 | 23.7 | 49.8 | -135.3 | -241.332 | -178.211 | -183.985 | -235.515 | -161.443 | -123.767 | -112.945 | -102.103 |
| Income Before Tax
| 11,139.3 | 7,452.5 | 9,094.8 | 9,001.8 | 6,639.7 | 5,142.7 | 6,225.5 | 6,481.7 | 5,474 | 4,560.1 | 3,298.5 | 1,767.9 | 909.583 | 565.664 | 387.609 | 298.143 | 288.792 | 193.725 | 142.52 | 93.986 |
| Income Before Tax Ratio
| 0.265 | 0.199 | 0.277 | 0.316 | 0.259 | 0.255 | 0.302 | 0.338 | 0.321 | 0.313 | 0.279 | 0.192 | 0.134 | 0.112 | 0.095 | 0.085 | 0.093 | 0.075 | 0.062 | 0.047 |
| Income Tax Expense
| 2,977.6 | 1,572.7 | 1,968 | 2,463.1 | 1,962.7 | 1,273 | 1,539.1 | 1,413.4 | 1,459.9 | 1,461.5 | 959.7 | 646.8 | 136.926 | 58.538 | 47.572 | 43.832 | 68.498 | 46.674 | 18.351 | -5.482 |
| Net Income
| 8,161.7 | 5,879.8 | 7,126.8 | 6,538.7 | 4,677 | 3,869.7 | 4,686.4 | 5,068.3 | 4,014.1 | 3,098.6 | 2,338.8 | 1,121.1 | 772.657 | 507.126 | 340.037 | 254.311 | 218.807 | 146.612 | 123.462 | 98.493 |
| Net Income Ratio
| 0.194 | 0.157 | 0.217 | 0.23 | 0.183 | 0.192 | 0.228 | 0.264 | 0.235 | 0.213 | 0.198 | 0.122 | 0.114 | 0.1 | 0.083 | 0.073 | 0.071 | 0.057 | 0.054 | 0.05 |
| EPS
| 64.82 | 45.89 | 54.97 | 50.06 | 35.73 | 29.32 | 35.5 | 38.39 | 31.49 | 23.49 | 17.75 | 8.51 | 5.86 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| EPS Diluted
| 64.77 | 45.89 | 54.96 | 50.06 | 35.73 | 29.31 | 35.5 | 38.39 | 31.49 | 23.47 | 17.71 | 8.49 | 5.85 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| EBITDA
| 11,719.4 | 8,818.9 | 10,234.6 | 10,219.5 | 7,919.9 | 5,824.2 | 6,795.1 | 7,209.5 | 6,008.8 | 5,187.9 | 3,802.4 | 2,243.2 | 1,469.607 | 991.36 | 795.914 | 675.646 | 528.977 | 404.939 | 352.453 | 287.8 |
| EBITDA Ratio
| 0.278 | 0.236 | 0.312 | 0.359 | 0.309 | 0.289 | 0.33 | 0.376 | 0.352 | 0.357 | 0.322 | 0.243 | 0.217 | 0.196 | 0.195 | 0.193 | 0.171 | 0.157 | 0.153 | 0.145 |